Gilead Sciences (GILD)

Gilead Sciences Financial Statements


Gilead Sciences Financial Overview

Gilead Sciences's market cap is currently ―. The company's EPS TTM is $3.279; its P/E ratio is 19.76; and it has a dividend yield of 4.54%. Gilead Sciences is scheduled to report earnings on October 27, 2022, and the estimated EPS forecast is $1.55. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Mar 22Dec 21Sep 21Jun 21
Income Statement
Total Revenue$ 6.26B$ 6.59B$ 7.24B$ 7.42B$ 6.22B
Gross Profit$ 4.82B$ 5.17B$ 4.62B$ 6.20B$ 4.83B
EBIT$ 1.75B$ 86.00M$ 997.00M$ 3.69B$ 2.07B
EBITDA$ 2.27B$ 611.00M$ 1.53B$ 4.21B$ 2.59B
Net Income Common Stockholders$ 1.14B$ 19.00M$ 382.00M$ 2.59B$ 1.52B
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 5.66B$ 5.33B$ 6.52B$ 5.74B$ 6.53B
Total Assets$ 62.87B$ 63.08B$ 67.95B$ 67.10B$ 67.98B
Total Debt$ 26.22B$ 26.21B$ 26.68B$ 26.69B$ 30.17B
Net Debt$ 20.55B$ 20.88B$ 20.16B$ 20.95B$ 23.65B
Total Liabilities$ 42.66B$ 43.16B$ 46.89B$ 45.63B$ 48.27B
Stockholders Equity$ 20.24B$ 19.93B$ 21.07B$ 21.47B$ 19.70B
Cash Flow
Free Cash Flow$ 1.66B$ 1.59B$ 3.05B$ 3.11B$ 2.20B
Operating Cash Flow$ 1.80B$ 1.84B$ 3.21B$ 3.25B$ 2.32B
Investing Cash Flow$ -308.00M$ -1.07B$ -278.00M$ -234.00M$ -577.00M
Financing Cash Flow$ -1.00B$ -1.79B$ -1.94B$ -3.53B$ -931.00M
Currency in USD

Gilead Sciences Earnings and Revenue History

Gilead Sciences Debt to Assets

Gilead Sciences Cash Flow

Gilead Sciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis